Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Long-Term Debt Repayments (2016 - 2021)

Historic Long-Term Debt Repayments for Pharma-Bio Serv (PBSV) over the last 12 years, with Q2 2021 value amounting to $64228.0.

  • Pharma-Bio Serv's Long-Term Debt Repayments rose 224494.34% to $64228.0 in Q2 2021 from the same period last year, while for Apr 2022 it was $64228.0, marking a year-over-year decrease of 1161.45%. This contributed to the annual value of $11030.0 for FY2020, which is 8370.42% down from last year.
  • Pharma-Bio Serv's Long-Term Debt Repayments amounted to $64228.0 in Q2 2021, which was up 224494.34% from $2851.0 recorded in Q1 2021.
  • Pharma-Bio Serv's 5-year Long-Term Debt Repayments high stood at $64228.0 for Q2 2021, and its period low was $2631.0 during Q3 2019.
  • Moreover, its 5-year median value for Long-Term Debt Repayments was $3306.5 (2018), whereas its average is $11967.9.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first plummeted by 9535.71% in 2020, then soared by 224494.34% in 2021.
  • Pharma-Bio Serv's Long-Term Debt Repayments (Quarter) stood at $3263.0 in 2017, then increased by 22.25% to $3989.0 in 2018, then tumbled by 33.19% to $2665.0 in 2019, then increased by 5.55% to $2813.0 in 2020, then soared by 2183.26% to $64228.0 in 2021.
  • Its Long-Term Debt Repayments stands at $64228.0 for Q2 2021, versus $2851.0 for Q1 2021 and $2813.0 for Q4 2020.